table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
Immunosuppressants drugs
abatacept ACTIV-1 abatacept
adalimumab Fakharian
anakinra SAVE-MORE CORIMUNO-ANA-1
anti-interleukin-6
Levilimab V.Lomakin ...
sarilumab CORIMUNO-SARI-1 ... sarilumab Sanofi phase 3 US REMAP-CAP sarilumab sarilumab Sanofi phase 3 outside US
sarilumab high dose (400mg) sarilumab phase 2 high dose Lescure ...
sarilumab low dose (200mg) sarimulab phase 2 low dose Lescure ...
tocilizumab EMPACTA RECOVERY NCT04479358 ... NCT04434717 ... Soin AS ... RCT-TCZ-COVID-19 NCT04412772 ... Declercq J ... NCT04577534 ... Rutgers EU-CTR2020-001375-32 ... Dongsheng Wang EU-CTR2020-001748-24 ... TOCOVID BACC Bay Tocilizumab Trial Hamed MARIPOSA Sarhan CORIMUNO-TOCI-ICU ... Sarhan CORIMUNO-TOCI-1 ... REMAP-CAP ... NCT04377750 ... Rashad Rosas ... Veiga Talaschian COVACTA ...
canakinumab Sheng ... CAN-COVID
cenicriviroc ACTIV-1 cenicriviroc
infliximab ACTIV-1 infliximab
itolizumab Kumar
janus kinase (JAK) inhibitor
baricitinib COV-BARRIER ACTT-2 ... RECOVERY COV-BARRIER ...
ruxolitinib Cao DEVENT
TD-0903
TD-0903 10mg Singh ...
TD-0903 1mg Singh ...
TD-0903 3mg Singh ...
tofacitinib STOP-COVID ... Murugesan
lenzilumab LIVE-AIR ...
tacrolimus TACROVID
thalidomide Amra

4 studies excluded by filtering options 1

5357 Cavalli, 2020 0130selection pending
5398 Ana-COVID (Huet), 2020 0133selection pending
6020 Annane, 2020 0130selection pending
6359 Kooistra, 2020 0100selection pending

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons